Minimally invasive surgery versus radiotherapy/chemoradiotherapy for early-stage oropharyngeal carcinoma

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 2, 2014, Pages

  Howard, James ^a   Masterson, Liam ^a   Dwivedi, Raghav C ^a   Riffat, Faruque ^b   Benson, Richard ^c   Jefferies, Sarah ^a   Jani, Piyush ^a   Tysome, James R ^a   Nutting, Chris ^d  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; EARLY CANCER; INTERMETHOD COMPARISON; MICROSURGERY; MINIMALLY INVASIVE SURGERY; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; ROBOT ASSISTED SURGERY; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; THERAPY EFFECT;

EID: 85003641934     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010963     Document Type: Article

References (38)

1. Adelstein DJ, Ridge JA, Brizel DM, Holsinger FC, Haughey BH, O'Sullivan B, et al. Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia. Head and Neck 2012;34(12):1681-703.
2. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. New England Journal of Medicine 2010;363(1):24-35.
3. Mehanna H. Oropharyngeal cancer. In: Roland N, Paleri V, MacKenzie K, Clarke P, Homer J, Pracy P editor(s). Head and Neck Cancer: Multidisciplinary Management Guidelines. 4th Edition. London: British Association of Otorhinolaryngology, Head and Neck Surgery, 2011:137-46.
4. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. Journal of Clinical Oncology 2011;29(32):4294-301.
5. Chen AM, Li BQ, Jennelle RL, Lau DH, Yang CC, Courquin J, et al. Late esophageal toxicity after radiation therapy for head and neck cancer. Head and Neck 2010;32(2):178-83.
6. Christiansen H, Hermann RM, Martin A, Florez R, Kahler E, Nitsche M, et al. Long-term follow-up after transoral laser microsurgery and adjuvant radiotherapy for advanced recurrent squamous cell carcinoma of the head and neck. International Journal of Radiation Oncology, Biology, Physics 2006;65(4):1067-74.
7. Chung CH, Gillison ML. Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clinical Cancer Research 2009;15:6758-62.
8. National Institutes of Health, National Cancer Institute. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events. 4th Edition. US Department of Health and Human Services, 2009.
9. de Martel C, Ferlay F, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncology 2012;13(6):607-15.
10. Dwivedi RC, Kazi RA, Agrawal N, Nutting CM, Clarke PM, Kerawala CJ, et al. Evaluation of speech outcomes following treatment of oral and oropharyngeal cancers. Cancer Treatment Reviews 2009;35(5):417-24. [PUBMED: 19481871]
11. Evans M, Powell NG. The changing aetiology of head and neck cancer: the role of human papillomavirus. Clinical Oncology 2010;22:538-46.
12. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. Journal of the National Cancer Institute 2008;100(4):261-9.
13. Genden EM, O'Malley BW Jr, Weinstein GS, Stucken CL, Selber JC, Rinaldo A, et al. Transoral robotic surgery: role in the management of upper aerodigestive tract tumors. Head and Neck 2012;34(6):886-93.
14. Grant DG, Hinni ML, Salassa JR, Perry WC, Hayden RE, Casler JD. Oropharyngeal cancer: a case for single modality treatment with transoral laser microsurgery. Archives of Otolaryngology -- Head and Neck Surgery 2009;135(12):1225-30. [DOI: 10.1001/archoto.2009.185]
15. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
16. Haughey BH, Hinni ML, Salassa JR, Hayden RE, Grant DG, RichJT, et al. Transoral laser microsurgery as primary treatment for advanced stage oropharyngeal cancer: a United States Multicentre Study. Head and Neck 2011;33(12):1683-94. [DOI: 10.1002/hed.21669]
17. Jackel MC, Martin A, Steiner W. Twenty five years experience with laser surgery for head and neck tumors. European Archives of Oto-Rhino-Laryngology 2007;264(6):577-85.
18. Lawson G, Matar N, Remacle M, Jamart J, Bachy V. Transoral robotic surgery for the management of head and neck tumors: learning curve. European Archives of Oto-Rhino-Laryngology 2011;268(12):1795-801. [DOI: 10.1007/s00405-011-1537-7]
19. Masterson L, Moualed D, Masood A, Dwivedi RC, Benson R, Sterling JC, et al. De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma. Cochrane Database of Systematic Reviews 2014, Issue 2. [DOI: 10.1002/14651858.CD010271.pub2]
20. Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, et al. The prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer: a systematic review and meta-analysis of trends by time and region. Head and Neck 2013;35(5):747-55. [DOI: 10.1002/hed.22015]
21. Moore EJ, Olsen KD, Kasperbauer JL. Transoral robotic surgery for oropharyngeal squamous cell carcinoma: a prospective study of feasibility and functional outcomes. Laryngoscope 2009;119(11):2156-64. [DOI: 10.1002/lary.20647]
22. Moore EJ, Hinni ML. Critical review: transoral laser microsurgery and robotic-assisted surgery for oropharynx cancer including human papillomavirus-related cancer. International Journal of Radiation Oncology, Biology, Physics 2013;85(5):1163-7.
23. Pfister DG, Ang K-K, Brizel DM, Burtness BA, Busse PM, Caudell JJ, et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Head and Neck Cancers. http://www.nccn.org 2013:1-175.
24. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
25. Parsons JT, Mendenhall WM, Stringer SP, Amdur RJ, Hinerman RW, Villaret DB, et al. Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer 2002;94(11):2967-80. [PUBMED: 12115386]
26. Pignon JP, Le Maitre A, Maillard E, Bourhis J, MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17, 346 patients. Radiotherapy and Oncology 2009;92(1):4-14.
27. Ramqvist T, Dalianis T. Oropharyngeal cancer epidemic and human papillomavirus. Emerging Infectious Diseases 2010;16:1671-7.
28. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
29. Rich JT, Liu J, Haughey BH. Swallowing function after transoral laser microsurgery - adjuvant therapy of advanced stage oropharyngeal cancer. Laryngoscope 2011;121(11):2381-90. [DOI: 10.1002/lary.21406]
30. Schache AG, Liloglou T, Risk JM, Filia A, Jones TM, Sheard J, et al. Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination. Clinical Cancer Research 2011;17:6262-71.
31. Singer S, Arraras J, Baumann I, Boehm A, Chie WC, Galalae R, et al. Quality of life in patients with head and neck cancer receiving targeted or multimodal therapy--update of the EORTC QLQ-H&N35, Phase I. Head and Neck 2013;35(9):1331-8.
32. Steiner W. Experience in endoscopic laser surgery of malignant tumours of the upper aero-digestive tract. Advances in Oto-Rhino-Laryngology 1988;39:135-44. [PUBMED: 2455969]
33. SudhoffHH, Schwarze HP, Winder D, Steinstraesser L, Gormer M, Stanley M, et al. Evidence for a causal association for HPV in head and neck cancers. European Archives of Oto-Rhino-Laryngology 2011;268:1541-7.
34. Weinstein GS, O'Malley Jr BW, Snyder W, Hockstein NG. Transoral robotic surgery: supraglottic partial laryngectomy. Annals of Otology, Rhinology and Laryngology 2007;116:19-23.
35. Weinstein GS, O'Malley BW Jr, Magnuson JS, Carroll WR, Olsen KD, Daio L, et al. Transoral robotic surgery: a multicenter study to assess feasibility, safety, and surgical margins. Laryngoscope 2012;122(8):1701-7.
36. Westra WH. The changing face of head and neck cancer in the 21st century: the impact of HPV on the epidemiology and pathology of oral cancer. Head and Neck Pathology 2009;3:78-81.
37. WHO. International Classification of Diseases for Oncology (ICD-O). 3rd Edition. Geneva: World Health Organization, 2000.
38. Williams CE, Kinshuck AJ, Derbyshire SG, Upile N, Tandon S, Roland NJ, et al. Transoral laser resection versus lip-split mandibulotomy in the management of oropharyngeal squamous cell carcinoma (OPSCC): a case match study. European Archives of Oto-Rhino-Laryngology 2013 May 4 [Epub ahead of print]. [PUBMED: 23644937]